The three unprecedented outbreaks of emerging human coronavirus (HCoV) infections at
the beginning of the twenty-first century have highlighted the necessity for readily available …

Respiratory viruses, including coronaviruses, are known to have a high incidence of
infection during winter, especially in temperate regions. Dry and cold conditions during …

Background Antigen point-of-care tests (AgPOCTs) can accelerate SARS-CoV-2 testing. As
some AgPOCTs have become available, interest is growing in their utility and performance …

The global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) has resulted in more than 129 million confirm cases. Many health authorities around …

UV light-emitting diodes (UV LEDs) are an emerging technology and a UV source for
pathogen inactivation, however low UV-LED wavelengths are costly and have low fluence …

Background Community-acquired pneumonia is a leading infectious cause of hospitalization
and death among US adults. Incidence estimates of pneumonia confirmed radiographically …

Background Incidence estimates of hospitalizations for community-acquired pneumonia
among children in the United States that are based on prospective data collection are …

About 200 million cases of viral community-acquired pneumonia occur every year—100
million in children and 100 million in adults. Molecular diagnostic tests have greatly …

Background. Recent trials suggest procalcitonin-based guidelines can reduce antibiotic use
for respiratory infections. However, the accuracy of procalcitonin to discriminate between …

Human coronaviruses (HCoVs) enter cells via two distinct pathways: the endosomal
pathway using cathepsins to activate spike protein and the cell-surface or early endosome …